October 13, 2023

RBDCOV project members met at Vall d’Hebron this week to move forward in the development of the BIMERVAX® vaccine. RBDCOV is an EU-funded project that aims to test the HIPRA vaccine against COVID-19 in children (including adolescents) and immunocompromised individuals. The meeting provided a chance to outline the forthcoming steps in the research of the vaccine and to update on the provisional results of the study in immunocompromised adults, confirming its safety and efficacy.

Asphalion is proud regulatory partner of RBDCOV by carrying out the regulatory pathway throughout the whole project by seeking scientific advice for the RBDCOV clinical trials with the European regulatory authorities, preparing the required documents to support clinical trial applications and supporting the preparation of the eCTD registration dossier currently under rolling review, among other regulatory activities.

For more details about the project, have a look at the project´s website: RBDCOV Project Website

For further information, you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category


Related news and events


BIO-Europe fall 2023, Europe´s largest gathering of biopharma professionals in Europe  will start next week and Asphalion expert Michael Schaub will be attending! PartneringONE is

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting